Difference between revisions of "WSI21-216-Case-2"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 68: Line 68:
 
|subject=Z0FBQUFBQmhxVFVNTExBUmp5R04tY3ZTTkRtUnAtZXhUajlVbWVoazg3YmtUWURFbXlWMTRiZU1BWHZ4SEhrbGMwaDAtTzRpVUpFYlUzc3BfMGR1Y21BSWRKN3NQLUJKS1J0UzlPOURscjV1Tm91QWlQQ3IyY1E9
 
|subject=Z0FBQUFBQmhxVFVNTExBUmp5R04tY3ZTTkRtUnAtZXhUajlVbWVoazg3YmtUWURFbXlWMTRiZU1BWHZ4SEhrbGMwaDAtTzRpVUpFYlUzc3BfMGR1Y21BSWRKN3NQLUJKS1J0UzlPOURscjV1Tm91QWlQQ3IyY1E9
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Vn048
 +
|authoredOn=December 02, 2021 09:03:06 PM
 
}}
 
}}

Latest revision as of 14:14, December 9, 2024

WSI21-216-Case-2
22 yo with hyperleukocytosis (WBC 78) and anemia (HGB: 9; HCT: 28.5%; MCV:81), concerning for acute myeloid leukemia.
Chronic myeloid leukemia, morphologically in chronic phase.
December 8, 2021 12:00:00 AM